Company / Gross Profit
Nuvation Bio Inc. Gross Profit History
FY2023-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit
$795.0K
FY2024
5-year range
$0 / $795.0K
FY2023-FY2024
Trend
-
vs FY2023
Sector context
#30 of 29
Health Care
What the data says
Among 29 Health Care companies, Nuvation Bio Inc. is in the bottom -3% for gross profit.
Based on SEC 10-K filings.
$795,000 in FY2024.
Health Care sector context is included.
Gross Profit over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom -3% in Health CareTop 103% of 29This company $795.0K Sector average $3.5B
▼
-100.0% below sector average
Key checks
Key Insights
- Ranks #30 out of 29 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -1.56 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross ProfitValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $795.0K | - |
| FY2023 | $0 | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
As of FY2024 · SEC 10-K · Updated Mar 29, 2026